US Molecular Diagnostics Market Outlook


In the United States, Cancer is a leading cause of death that can be detected early because of molecular diagnostic tests. United States molecular diagnostics market is anticipated to cross US$ 9 billion by the end of year 2024.
The United States molecular diagnostics market based on application; the market is broadly characterized into Oncology Test, Infectious diseases, Genetic tests. The Oncology molecular diagnostics market is determined by technological advancements, growing prevalence of cancer, and rising focus on personalized medicine.

Read »
Created by renubresearch 3 years 32 weeks ago – Made popular 3 years 31 weeks ago
Category: Health   Tags: